Factor | Quintana.Hayashi_2012_AppandEnvMic (10322)

10.1128/AEM.07723-11

Production Type

Swine | Other

9

Description

Predominantly C. coli (99.8%), sampled at farrowing, nursery, and finishing.

Resistance Outcomes

Resistance Microbe Outcome
Tetracycline
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 48.20 903
Conventional 88.30 1099
Azithromycin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 27.70 903
Conventional 25.30 1099
Ciprofloxacin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 1.20 903
Conventional 17.10 1099
Erythromycin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 27.50 903
Conventional 25.20 1099
Nalidixic Acid
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 1.30 903
Conventional 16.70 1099
Telithromycin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 20.90 903
Conventional 15.70 1099
Gentamicin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 0.10 903
Conventional 0.00 1099
Florfenicol
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 0.00 903
Conventional 0.00 1099
Clindamycin
/
Campylobacter coli
See: Table 3 AMR+ (%) AMR- (%) Total (n)
Antibiotic Free 12.50 903
Conventional 3.50 1099